Photo from Khaled Musallam/LinkedIn
May 27, 2024, 14:32
Khaled Musallam: Abstracts presented during the WIN Symposium 2024 are now published in the Journal of Immunotherapy and Precision Oncology
Khaled Musallam, Founding Director of Center for Research on Rare Blood Disorders (CR-RBD) at Burjeel Holdings, shared on their LinkedIn:
”Happy to share that abstracts presented during the WIN Symposium 2024 are now published in the Journal of Immunotherapy and Precision Oncology.”
Read further.
Source: Khaled Musallam/LinkedIn